World's Best Scientists 2026 revealed!
Takayuki Yoshimoto

Takayuki Yoshimoto

D-Index & Metrics

Immunology

D-Index
48
Citations
8300
World Ranking
4438
National Ranking
170

Takayuki Yoshimoto publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Takayuki Yoshimoto sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 149 publications — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Takayuki Yoshimoto D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Takayuki Yoshimoto sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 48 D-Index — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Takayuki Yoshimoto is a researcher affiliated with Tokyo Medical University in Japan, specializing primarily in the fields of Medicine and Immunology and Microbiology. Their work extensively covers topics related to mesenchymal stem cell research and immune system function.

Yoshimoto's main research areas include:

  • Mesenchymal stem cell research
  • Immune cell function and interaction
  • Immunotherapy and immune responses
  • Contact dermatitis and allergies
  • Hemostasis and retained surgical items
  • Wound healing and treatments
  • Breast cancer treatment studies

Their publications reflect a focus on these topics, appearing frequently in journals such as the International Journal of Molecular Sciences and Scientific Reports, as well as Frontiers in Immunology, Gels, and the Journal of Medical Case Reports. Yoshimoto has published notably in:

  • International Journal of Molecular Sciences (4 publications)
  • Scientific Reports (4 publications)
  • Frontiers in Immunology (2 publications)
  • Gels (2 publications)
  • Journal of Medical Case Reports (2 publications)

Recent research papers authored or co-authored by Yoshimoto include:

  • "Immortalization of Mesenchymal Stem Cells for Application in Regenerative Medicine and Their Potential Risks of Tumorigenesis" (2024, International Journal of Molecular Sciences)
  • "Rap1 prevents colitogenic Th17 cell expansion and facilitates Treg cell differentiation and distal TCR signaling" (2022, Communications Biology)
  • "Interleukin-1β in peripheral monocytes is associated with seizure frequency in pediatric drug-resistant epilepsy" (2021, Journal of Neuroimmunology)
  • "Chemical- and Drug-Induced Allergic, Inflammatory, and Autoimmune Diseases Via Haptenation" (2023, Biology)
  • "Water-Absorbing Bioadhesive Poly(Acrylic Acid)/Polyvinylpyrrolidone Complex Sponge for Hemostatic Agents" (2022, Bioengineering)

Yoshimoto has collaborated frequently with several co-authors, indicating active research partnerships. Key collaborators include:

  • Yasuhiro Katahira
  • Izuru Mizoguchi
  • Hideaki Hasegawa
  • Satomi Miyakawa
  • Shinya Inoué

Their publication record spans multiple subfields such as Immunology, Genetics, Oncology, Surgery, and Physiology. This interdisciplinary approach supports a range of investigations primarily focused on immune-related diseases, cancer treatments, and regenerative therapies.

Best Publications

  • The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis

    Christoph Hölscher;Alexandra Hölscher;Dominik Rückerl;Takayuki Yoshimoto

  • Potent Antitumor Activity of Interleukin-27

    Masayuki Hisada;Sadahiro Kamiya;Koji Fujita;Maria Laura Belladonna

  • An Indispensable Role for STAT1 in IL-27-Induced T-bet Expression but Not Proliferation of Naive CD4 + T Cells

    Sadahiro Kamiya;Toshiyuki Owaki;Noriko Morishima;Fumio Fukai

  • IL-27 Suppresses Th2 Cell Development and Th2 Cytokines Production from Polarized Th2 Cells: A Novel Therapeutic Way for Th2-Mediated Allergic Inflammation

    Tomohiro Yoshimoto;Takayuki Yoshimoto;Koubun Yasuda;Junichiro Mizuguchi

  • A Role for IL-27 in Early Regulation of Th1 Differentiation

    Toshiyuki Owaki;Masayuki Asakawa;Noriko Morishima;Kikumi Hata

  • Augmentation of Effector CD8 + T Cell Generation with Enhanced Granzyme B Expression by IL-27

    Noriko Morishima;Toshiyuki Owaki;Masayuki Asakawa;Sadahiro Kamiya

  • Regulation of Antitumor Immune Responses by the IL-12 Family Cytokines, IL-12, IL-23, and IL-27

    Mingli Xu;Izuru Mizoguchi;Noriko Morishima;Yukino Chiba

  • Pivotal Roles of T-Helper 17-Related Cytokines, IL-17, IL-22, and IL-23, in Inflammatory Diseases

    Ning Qu;Mingli Xu;Izuru Mizoguchi;Jun Ichi Furusawa

  • Antiangiogenic and Antitumor Activities of IL-27

    Motomu Shimizu;Mariko Shimamura;Toshiyuki Owaki;Masayuki Asakawa

  • Notch signaling drives IL-22 secretion in CD4+ T cells by stimulating the aryl hydrocarbon receptor

    Muhammad Shamsul Alam;Yoichi Maekawa;Akiko Kitamura;Kenji Tanigaki

  • Genetic defect in T lymphocyte-specific homing into peripheral lymph nodes

    Hideki Nakano;Toshiki Tamura;Takayuki Yoshimoto;Hideo Yagita

  • Induction of IgG2a Class Switching in B Cells by IL-27

    Takayuki Yoshimoto;Keiko Okada;Keiko Okada;Noriko Morishima;Sadahiro Kamiya

  • IL-27 Suppresses CD28-Medicated IL-2 Production through Suppressor of Cytokine Signaling 3

    Toshiyuki Owaki;Masayuki Asakawa;Sadahiro Kamiya;Kiyoshi Takeda

  • Calpain-induced Bax-cleavage product is a more potent inducer of apoptotic cell death than wild-type Bax.

    Hiroko Toyota;Noriko Yanase;Takayuki Yoshimoto;Masami Moriyama

  • Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma.

    Shuntaro Oniki;Hiroshi Nagai;Tatsuya Horikawa;Junya Furukawa

  • Expanding Diversity in Molecular Structures and Functions of the IL-6/IL-12 Heterodimeric Cytokine Family

    Hideaki Hasegawa;Izuru Mizoguchi;Yukino Chiba;Mio Ohashi

  • Antiproliferative Activity of IL-27 on Melanoma

    Takayuki Yoshimoto;Noriko Morishima;Izuru Mizoguchi;Motomu Shimizu

  • IL-27 induces Th1 differentiation via p38 MAPK/T-bet- and intercellular adhesion molecule-1/LFA-1/ERK1/2-dependent pathways.

    Toshiyuki Owaki;Masayuki Asakawa;Fumio Fukai;Junichiro Mizuguchi

  • Interferon-gamma is a therapeutic target molecule for prevention of postoperative adhesion formation.

    Hisashi Kosaka;Tomohiro Yoshimoto;Takayuki Yoshimoto;Jiro Fujimoto

  • Interleukin-27 Activates Natural Killer Cells and Suppresses NK-Resistant Head and Neck Squamous Cell Carcinoma through Inducing Antibody-Dependent Cellular Cytotoxicity

    Masahiro Matsui;Tsunao Kishida;Hiroshi Nakano;Koichiro Yoshimoto

Frequent Co-Authors

Yoichiro Iwakura
Yoichiro Iwakura Tokyo University of Science
Daniel J. Cua
Daniel J. Cua Johnson & Johnson (United States)
Susumu Nakae
Susumu Nakae Hiroshima University
Tomohiro Yoshimoto
Tomohiro Yoshimoto Hyogo College of Medicine
Kiyoshi Takeda
Kiyoshi Takeda Osaka University
Masahiko Kuroda
Masahiko Kuroda Tokyo Medical University
Hiroyasu Nakano
Hiroyasu Nakano Toho University
Kazuma Ohyashiki
Kazuma Ohyashiki Tokyo Medical University
Katsuko Sudo
Katsuko Sudo Tokyo Medical University
Stefan Ehlers
Stefan Ehlers Kiel University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in immunology often leads students to explore various advanced nursing roles, particularly those specializing in patient care and mental health. For individuals interested in merging immunology with psychiatric care, the best psychiatric mental health nurse practitioner programs online offer comprehensive education coupled with strong clinical placements. These programs help bridge the gap between immunology knowledge and patient-centered mental health services.

Cost is a significant factor for many students. Fortunately, there are affordable pmhnp programs that make advanced education more accessible without sacrificing quality. This is crucial for professionals seeking to specialize without heavy financial burdens.

Salary expectations vary by role and geographic location. According to data about how much does a dnp make, Doctor of Nursing Practice graduates can anticipate competitive compensation, especially when working in specialized fields tied to immunology and patient care.

For nurses looking to expand their expertise, understanding the pathway from family nursing to acute care is vital. Resources like fnp to acute care np guide professionals through the transition, opening doors to more acute and specialized patient care roles aligned with immunological conditions.

Best Scientists Citing Takayuki Yoshimoto

Trending Scientists

Recently Published Articles